Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by MrMugsy on Feb 25, 2021 4:05pm

Dan ...

Like I said - there are two camps on Dan and you need to respect that.
I'm not saying you have to be in either camp - which side you choose is up to you.
---------------
What I am saying is there's always more to the story than is often discussed.
Many don't know the whole story.

Hope that helps.
Comment by Layth1990 on Feb 25, 2021 4:17pm
Everyone is upset because what happened killed the nuance rally. Ofcourse there is more into the story than this. I'm sure the managment will kill the sp more once they announce IP deal with the holding. Things could be excuted in a better way.  basically anyone who boughy at the latest offering or during the nuance deal are down at least 25%. Those are new investors and managment just ...more  
Comment by MrMugsy on Feb 25, 2021 4:34pm
And all will pass - sitting in the best financial position ever - lots of potential.  The sadness will eventually evaporate.  IMO. ----- There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antibe Therapeutics (ATBPF) and United Therapeutics (UTHR) with bullish sentiments. Antibe Therapeutics (ATBPF) In a report released today, Tania ...more  
Comment by WalkOverTheStrt on Feb 25, 2021 4:47pm
MrMugsy - yes if they execute the science the vaue will eventually be seen in the MC. That state why did they choose to raise now and not allow the SP to increase as they added new secondary market partners or had other positive events to help drive the price (PH3 start, dosing finalized) or even better perform the raise after they were on the NASDAQ. If the raise from what it sounds was highly ...more  
Comment by MrMugsy on Feb 25, 2021 5:14pm
That's the beauty of it - if you have questions - you can ask Dan directly ... rather than wonder what happened.  Dan will answer you !  
Comment by Layth1990 on Feb 25, 2021 4:51pm
Ofcourse they will rate 14.5cad/share because everyone who invested are banging their heads against the wall.  don't get me wrong! My average is really low and i'm long on ate. I think it is not fair for the new investors to be set this way. Put youtself in their shoes, -25% at least in couple of days!  i'm not really a fan of dan and i believe things would be much better ...more  
Comment by Doccole on Feb 25, 2021 5:05pm
If the science prevails, we will do fine.  It's unfortunate that this is in Canada, and the CEO cares little about retail investors.  Every dilution comes with a bonus for the  executive staff.  
Comment by WalkOverTheStrt on Feb 25, 2021 5:13pm
So the underwriter stands behind their pps rating... ummmmm TORONTO, Feb. 17, 2021 /CNW/ - Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSX: ATE) today announced that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (together, the "Underwriters") and pursuant to which the Underwriters have ...more  
Comment by Forestview on Feb 25, 2021 5:19pm
The more I read these comments, the more angry I get at Dan and his shortsightedness and, quite frankly, ineptitude with the BD.  I will admit that the market are partly tanking due to the bond yield increases, as my entire portfolio is in red.  But, like many here, I have little confidence in Dan.   What if we sells Otena for less than what the market deems its worth?  ...more  
Comment by 123ABC on Feb 25, 2021 5:34pm
You aren't paid to post how great management is on this board so you may not get an answer.
Comment by Forestview on Feb 25, 2021 5:53pm
And, further to my point - Dan has no incentive to keep the SP high in the short-term, since the lower it is, the more shares he and Wallace get back for any amalgamation with AH, which only further benefits him.  So, we will all be watered down because of this.  My anger is palpable.  I need a drink.
Comment by MrMugsy on Feb 25, 2021 6:05pm
Forestview - get me a Rye and Coke while you're up      : ) To your point, hoping that when we file the IND (which should be anytime now) - that the next leg of excitement begins.  We're not Phase 3 until FDA says we are (or that's how I see it).  With the right proof in front of the FDA, hope it's smooth sailing into P3 and shareholder excitement ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities